newsfilter
← Latest News
Business Wire·

Agomab Bolsters Executive Team with Appointment of Pierre Kemula as Chief Financial Officer

Agomab Therapeutics NV (‘Agomab') today announced that Pierre Kemula will join the company as Chief Financial Officer (CFO) effective November 1, 2024, bringing more than 15 years of experience in global biotech